Advertisement
+ News Categories + Corporate Categories + Report Categories

NEXT ARTICLE

me2me AG and MedAptus Partner to Provide Advanced Mobile Charge Capture, Dictation and Workflow Solutions to Physician Groups

09:50 EST 15 Nov 2011 | Advantage Business Media

Baar, Switzerland, November 15, 2011 - me2me AG, a software company delivering mobile dictation, transcription and speech recognition solutions, and MedAptus®, the market leader for charge capture technologies, today announced an agreement for m..

Related Biotechnology, Pharmaceutical and Healthcare News

Original Article: me2me AG and MedAptus Partner to Provide Advanced Mobile Charge Capture, Dictation and Workflow Solutions to Physician Groups

Advantage Business Media

 Channels 41 Associated Channels :: Search

  • Palliative Care

    Palliative care is the active holistic care of patients with advanced progressive illness. Management of pain and other symptoms and provision of psychological, social and spiritual support is param...

  • Opal Events

    Opal Events coordinates leading pharmaceutical, healthcare and investment management conferences across the United States, Europe and South America. These events provide delegates with the nece...

  • Prostate Cancer

    Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or...

  • Mesenchymal Epithelial Transition factor c MET

    The c-MET signalling pathway consists of the mesenchymal epithelial transition factor (c-MET) transmembrane tyrosine kinase receptor and its ligand hepatocyte growth factor (HGF) or scatter factor (SF...

  • Siemens

    Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...

  • Janus Kinase JAK Inhibitors

    As cytokines play pivotal roles in immunity and inflammation, targeting of cytokines and their receptors represents an effective means of treating such diseases. Janus kinases (JAK) are a small family...

  • Macular Degeneration AMD

    Macular degeneration in the elderly (AMD) is a major cause of blindness. Its prevalence increases to 30% in patients 75 to 85 years of age. AMD occurs in two forms: dry and wet AMD. Central geograph...

  • Antibody Drug Conjugates ADC

    The humanized anti-Her2 monoclonal antibody Herceptin (trastuzumab) has become the mainstay in the treatment of Her2-positive breast cancer. Combining trastuzumab with the potent cytotoxic DM1 via a s...

  • CurrentPartnering

    CurrentPartnering was established in 2007 to offer an objective and informal business tool for business development executives, providing an opportunity for the dissemination of the latest trends in...

  • Maryland

    Maryland, the US state on the mid-Atlantic coast, is hub of biotechnology institutions and companies. In 2005/2006 is was the 2nd best area globally for initiatives aimed at drawing and retaining bi...

Associated Content for this Article